Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer

Valesca P. Retel, Manuela A. Joore, Michael Knauer, Sabine C. Linn, Michael Hauptmann, Wim H. van Harten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1382-1391
JournalEuropean Journal of Cancer
Issue number8
Publication statusPublished - May 2010


  • Breast cancer
  • Cost-effectiveness
  • Gene expression profiling
  • 70-Gene MammaPrint (R) signature

Cite this